You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • AB0416 Which factors predict the responsiveness to tocilizumab in rheumatoid arthritis? the difference between the usage as the first biologic and as the second biologic

Article metrics

Article menu

Download PDFPDF

Abstracts Accepted for Publication
Rheumatoid arthritis - other biologic treatment
AB0416 Which factors predict the responsiveness to tocilizumab in rheumatoid arthritis? the difference between the usage as the first biologic and as the second biologic
Free

 

Online download statistics by month:

Online download statistics by month: June 2017 to March 2024

AbstractFullPdf
Jun 2017400
Jul 20172001
Aug 2017600
Sep 20173202
Oct 20171202
Nov 20171200
Dec 2017600
Jan 20182004
Feb 20181401
Mar 20181400
Apr 20181604
May 20183601
Jun 2018600
Jul 2018800
Aug 20181602
Oct 2018400
Nov 2018402
Dec 20181004
Feb 2019201
Mar 2019203
Apr 2019002
May 2019002
Jun 2019201
Jul 2019403
Aug 2019004
Sep 2019001
Oct 2019202
Dec 2019001
Feb 2020001
Mar 2020001
Apr 2020001
May 2020001
Jun 2020604
Jul 2020801
Aug 2020202
Sep 2020801
Oct 2020201
Nov 2020201
Dec 2020401
Jan 2021204
Feb 2021001
Mar 2021202
Apr 2021202
May 2021203
Jun 2021001
Jul 2021005
Sep 2021003
Oct 20214020
Nov 2021209
Dec 2021403
Jan 2022001
Feb 20221606
Mar 2022001
Apr 20221703
May 20221007
Jun 20221003
Jul 2022800
Aug 20221402
Sep 2022207
Oct 2022405
Nov 2022401
Dec 2022400
Jan 2023401
Feb 2023201
Mar 2023800
May 2023202
Jul 2023203
Aug 2023001
Sep 2023201
Oct 2023001
Nov 20230052
Dec 20231201
Jan 2024200
Feb 2024201
Mar 2024400
Total4310211